Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank29
Studio
Year-over-Year Change

Free cash flow yield

Latest
-39.75%
Near historical average
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthNormalizing
Average
-40.39%
Historical baseline
PeriodValueYoY Change
2024-39.75%+15.8%
2023-47.19%+77.2%
2022-206.88%-1129.4%
2021-16.83%-168.1%
2020-6.28%-101.2%
2019-3.12%-85.7%
2018-1.68%-20.2%
2017-1.40%-